CS Diagnostics Corp. (CSDX)
OTCMKTS
· Delayed Price · Currency is USD
0.2499
+0.0499 (24.95%)
Apr 17, 2025, 4:00 PM EDT
CS Diagnostics Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
1
Market Cap
27.47M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 16.04M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Northwest Biotherapeutics | 1.38M |
Glass House Brands | 200.90M |
BioStem Technologies | 210.49M |
American Oncology Network | 1.76B |
CS Diagnostics News
- 2 days ago - CS Diagnostics Corp. is Entering into a $5 Million Loan Agreement with SAN ART CAPITAL SAS - Accesswire
- 5 weeks ago - OTCQB-CSDX Appoints Lachman Consultants for CS-Protect Hydrogel FDA Approval - Accesswire
- 3 months ago - CS Diagnostics Corp. Announces U.S. Launch of MEDUSA - Business Wire